Jenrin Discovery
Mr. Gardner has served as Chairman and Chief Executive Officer of Gardner Lewis Asset Management since the firm’s founding. Previously, he was a lead Portfolio Manager with Friess Associates and its Brandywine Fund. Prior to joining Friess Associates, he worked as an Investment Analyst with Investments Orange Nassau, a Netherlands-based venture capital firm, with interests in both private and public companies. This position stemmed from employment with MBank, then a $20 billion bank holding company, where he analyzed companies as well as industry groups.
Mr. Gardner began his investment career at Lehman Brothers Kuhn Loeb (prior to the Shearson Merger). He received his B.B.A. in Finance from Southern Methodist University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Jenrin Discovery
Jenrin Discovery is a privately-held, a company focused on the discovery and development of small-molecule product candidates designed to target peripheral tissues.